Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Chemmedchem|September 4, 2013
Tafamidis (Vyndaqel): a light for FAP patientsSusanna Nencetti, Armando Rossello, Elisabetta OrlandiniNeural Regeneration Research|April 28, 2021
Neuroglobin and neuroprotection: the role of natural and synthetic compounds in neuroglobin pharmacological inductionLidia Ciccone, Susanna Nencetti, Simone Socci, et al.Journal of Chemical Information and Modeling|November 25, 2010
Different binding modes of structurally diverse ligands for human D3DARGabriella Ortore, Tiziano Tuccinardi, Elisabetta Orlandini, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|May 19, 2020
Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: analysis of structural data for future drug designLidia Ciccone, Nicoló Tonali, Susanna Nencetti, et al.Molecules (Basel, Switzerland)|November 13, 2021
Carbonic Anhydrase Inhibitors and Epilepsy: State of the Art and Future PerspectivesLidia Ciccone, Chiara Cerri, Susanna Nencetti, et al.Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Pomegranate: A Source of Multifunctional Bioactive Compounds Potentially Beneficial in Alzheimer's DiseaseLidia Ciccone, Susanna Nencetti, Armando Rossello, et al.Pharmaceuticals (Basel, Switzerland)|January 27, 2021
Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer's DiseaseLidia Ciccone, Jennifer Vandooren, Susanna Nencetti, et al.International Journal of Molecular Sciences|September 28, 2024
A Snapshot of the Most Recent Transthyretin StabilizersCarlo Marotta, Lidia Ciccone, Elisabetta Orlandini, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|April 13, 2016
Synthesis and structural analysis of halogen substituted fibril formation inhibitors of Human Transthyretin (TTR)Lidia Ciccone, Susanna Nencetti, Armando Rossello, et al.Archiv Der Pharmazie|March 6, 2007
Synthesis and 5-HT2A, 5-HT1A and alpha1-binding affinities of 2-[2-Hydroxy-3-(pyridin-3-yl-methyl)amino]-, 2-[2-hydroxy-3-(2-pyridin-2-yl-ethyl)amino]- and 2-[2-hydroxy-3-(4-N-methyl-piperazin-1-yl)-amino]propoxybenzaldehyde-O-(substituted) benzyl oximesElisabetta Orlandini, Simona Rapposelli, Susanna Nencetti, et al.Pageof 7